ATC Group: C09DX Angiotensin II antagonists, other combinations

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C09DX in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C09 Agents acting on the renin-angiotensin system
3 C09D Angiotensin II antagonists, combinations
4 C09DX Angiotensin II antagonists, other combinations

Group C09DX contents

Code Title
C09DX01 Valsartan, amlodipine and hydrochlorothiazide
C09DX02 Valsartan and aliskiren
C09DX03 Olmesartan medoxomil, amlodipine and hydrochlorothiazide
C09DX04 Valsartan and sacubitril
C09DX05
C09DX06
C09DX07
C09DX08

Active ingredients in C09DX

Active Ingredient Description
Valsartan and Sacubitril
Valsartan, Amlodipine and Hydrochlorothiazide

Combination of three antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine that belongs to the calcium antagonist class and valsartan that belongs to the angiotensin II antagonist class of medicines and hydrochlorothiazide that belongs to the thiazide diuretics class of medicines. The combination of these substances has an additive antihypertensive effect.

Related product monographs

Title Information Source Document Type  
COPALIA HCT Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC
ENTRESTO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC